6NM6
Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to N6 FR3-03 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.2 Angstrom
6NM6 の概要
エントリーDOI | 10.2210/pdb6nm6/pdb |
分子名称 | Envelope glycoprotein gp41, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (15 entities in total) |
機能のキーワード | hiv-1 envelope prefusion trimer, cd4-binding site antibodies, chimeric antibodies, immune system |
由来する生物種 | Human immunodeficiency virus 1 詳細 |
タンパク質・核酸の鎖数 | 8 |
化学式量合計 | 188558.35 |
構造登録者 | |
主引用文献 | Liu, Q.,Lai, Y.T.,Zhang, P.,Louder, M.K.,Pegu, A.,Rawi, R.,Asokan, M.,Chen, X.,Shen, C.H.,Chuang, G.Y.,Yang, E.S.,Miao, H.,Wang, Y.,Fauci, A.S.,Kwong, P.D.,Mascola, J.R.,Lusso, P. Improvement of antibody functionality by structure-guided paratope engraftment. Nat Commun, 10:721-721, 2019 Cited by PubMed Abstract: Broadly neutralizing antibodies (bNAbs) represent a promising alternative to antiretroviral drugs for HIV-1 prevention and treatment. Selected antibodies to the CD4-binding site bolster envelope trimer binding via quaternary contacts. Here, we rationally engraft a new paratope, i.e., the extended heavy-chain framework region 3 (FR3) loop of VRC03, which mediates quaternary interaction, onto several potent bNAbs, enabling them to reach an adjacent gp120 protomer. The interactive quaternary surface is delineated by solving the crystal structure of two FR3 loop-chimeric antibodies. Chimerization enhances the neutralizing activity of several potent bNAbs against a majority of global HIV-1 strains. Compared to unmodified antibodies, chimeric antibodies display lower autoreactivity and prolonged in vivo half-life in huFcRn mice and rhesus macaques. Thus, paratope engraftment may be used to expand the epitope repertory of natural antibodies, improving their functionality for disease prevention and treatment. PubMed: 30760721DOI: 10.1038/s41467-019-08658-4 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.739 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード